Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be as...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Gastrointestinal Medicine |
| Online Access: | http://dx.doi.org/10.1155/2018/4324592 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566713541984256 |
|---|---|
| author | Muhammad Mirza Maira Mirza Vagishwari Murugesan Arrel Olano |
| author_facet | Muhammad Mirza Maira Mirza Vagishwari Murugesan Arrel Olano |
| author_sort | Muhammad Mirza |
| collection | DOAJ |
| description | Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion. |
| format | Article |
| id | doaj-art-d83d358e7ecf44979f155b66a6fdaf57 |
| institution | Kabale University |
| issn | 2090-6528 2090-6536 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Gastrointestinal Medicine |
| spelling | doaj-art-d83d358e7ecf44979f155b66a6fdaf572025-02-03T01:03:31ZengWileyCase Reports in Gastrointestinal Medicine2090-65282090-65362018-01-01201810.1155/2018/43245924324592Pericardial Effusion due to Infliximab Therapy for Ulcerative ColitisMuhammad Mirza0Maira Mirza1Vagishwari Murugesan2Arrel Olano3Department of Internal Medicine, Medstar Washington Hospital Center, USADepartment of Internal Medicine, Cambridge Health Alliance, USADepartment of Internal Medicine, Medstar Washington Hospital Center, USADepartment of Internal Medicine, Medstar Washington Hospital Center, USAUlcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion.http://dx.doi.org/10.1155/2018/4324592 |
| spellingShingle | Muhammad Mirza Maira Mirza Vagishwari Murugesan Arrel Olano Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis Case Reports in Gastrointestinal Medicine |
| title | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
| title_full | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
| title_fullStr | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
| title_full_unstemmed | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
| title_short | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
| title_sort | pericardial effusion due to infliximab therapy for ulcerative colitis |
| url | http://dx.doi.org/10.1155/2018/4324592 |
| work_keys_str_mv | AT muhammadmirza pericardialeffusionduetoinfliximabtherapyforulcerativecolitis AT mairamirza pericardialeffusionduetoinfliximabtherapyforulcerativecolitis AT vagishwarimurugesan pericardialeffusionduetoinfliximabtherapyforulcerativecolitis AT arrelolano pericardialeffusionduetoinfliximabtherapyforulcerativecolitis |